Overcoming multidrug resistance in cancer: An update on research of natural products

Drugs of the Future

Volumn 34, Issue 1, 2009, Pages 53-59

  Sun, Li Rui ^a   Cui, Shu Xiang ^b   Qu, Xian Jun ^a  

^a SHANDONG UNIVERSITY   (China)

^b SHANDONG PROVINCIAL HOSPITAL AFFILIATED TO SHANDONG FIRST MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

3,6 DIHYDROXYFLAVONE; 5 BROMOTETRANDRINE; ADENOSINE TRIPHOSPHATASE INHIBITOR; ALKALOID; ANTINEOPLASTIC AGENT; BIOCHANIN A; CYTARABINE; DAUNORUBICIN; DAURICINE; DEHYDROSILYBIN; EPIGALLOCATECHIN GALLATE; ETOPOSIDE; FLAVANOID; GALANGIN; GINSENOSIDE; GLUTATHIONE; GLYCOPROTEIN P; ISOKAEMPFERIDE; MORIN; MULTIDRUG RESISTANCE PROTEIN 1; MULTIDRUG RESISTANCE REVERSING DRUG; NATURAL PRODUCT; POLYPHENOL DERIVATIVE; QUERCETIN; SAPONIN; SILYMARIN; TETRANDRINE; UNCLASSIFIED DRUG; UNINDEXED DRUG; VINBLASTINE;

ACUTE GRANULOCYTIC LEUKEMIA; ANTINEOPLASTIC ACTIVITY; CANCER CELL; CANCER CHEMOTHERAPY; DOWN REGULATION; DRUG ACCUMULATION; DRUG ACTIVITY; DRUG BINDING SITE; DRUG EFFICACY; DRUG MECHANISM; DRUG PROTEIN BINDING; DRUG STRUCTURE; DRUG SYNTHESIS; DRUG TRANSPORT; ENZYME ACTIVITY; GROWTH INHIBITION; HERBAL MEDICINE; HUMAN; MULTIDRUG RESISTANCE; NONHUMAN; PRENYLATION; PROTEIN EXPRESSION; REVIEW; TEA; TREATMENT FAILURE; TREATMENT OUTCOME; UNSPECIFIED SIDE EFFECT;

EID: 72549108241     PISSN: 03778282     EISSN: None     Source Type: Journal    
DOI: 10.1358/dof.2009.034.01.1317151     Document Type: Review

References (44)

1. Wu, CP, Calcagno, A.M., Ambudkar, S.V. Reversal of ABC drug transporter-mediated multidrug resistance in cancer cells: Evaluation of current strategies. Curr Mol Pharmacol 2008,1(2): 93-105.
2. Vecchio, S.D., Zannetti, A, Salvatore, B., Paone, G., Fonti, R., Salvatore, M. Functional imaging of multidrug resistance in breast cancer. Phys Med 2006, 21(Suppl. 1): 24-7.
3. Cordo Russo, R.I, Garc, M.G., Alaniz, L., Blanco, G., Alvarez, E., Hajos, S.E. Hyaluronan oligosaccharides sensitize lymphoma resistant cell lines to vincristine by modulating P-glycoprotein activity and PI3K/Akt pathway. lnt J Cancer 2008,122:1012-8.
4. Fraunfelder, F.W. Ocular side effects associated with dietary supplements and herbal medicines. Drugs Today (Barc) 2005, 41(8): 537-45.
5. Kim, H.P., Son, K.H., Chang, H.K., Kang, S.S. Anti-inflammatory plant flavonoids and cellular action mechanisms. J Pharmacol Sci 2004, 96(3): 229-45.
6. Kandaswami, C., Lee, L.T., Lee, P.P., Hwang, J.J., Ke, F.C., Huang, Y.T., Lee, M.T. The antitumor activities of flavonoids. In Vivo 2005,19(5): 895-909.
7. Nakagawa-Goto, K., Bastow, K.F., Chen, T.H., Morris-Natschke, S.L., Lee, K.H. Antitumor agents 260. New desmosdumotin B analogues with improved in vitro anticancer activity. J Med Chem 2008, 51(11): 3297-303.
8. Chan, K.F., Zhao, Y., Burkett, B.A., Wong, I.L., Chow, L.M., Chan, T.H. Flavonoid dimers as bivalent modulators for P-glycoprotein-based multidrug resistance: Synthetic apigenin homodimers linked with defined-length poly (ethylene glycol) spacers increase drug retention and enhance chemosensitivity in resistant cancer cells. J Med Chem 2006, 49(23): 6742-59.
9. Aszalos, A. Role of ATP-binding cassette (ABC) transporters in interactions between natural products and drugs. Curr Drug Metab 2008,9(10): 1010-7.
10. Fu, L.W., Zhang, Y.M., Liang, Y.J., Yang, X.P., Pan, Q.C. The multidrug resistance of tumor cells was reversed by tetrandrine in vitro and in xenografts derived from human breast adenocarcinoma MCF-7/adr cells. Eur J Cancer 2002,38(3): 418-26.
11. Zhang, S., Morris, M.E. Effects of the flavonoids biochanin A, morin, phloretin, and Silymarin on P-glycoprotein-mediated transport. J Pharmacol Exp Ther 2003,304(3): 1258-67.
12. Al-Shawi, M.K., Polar, M.K., Omote, H., Figler, R.A. Transition state analysis of the coupling of drug transport to ATP hydrolysis by P-glycoprotein. J Biol Chem 2003,278(52): 52629-40.
13. 2+-ATPase by flavonoids: A quantitative structure-activity relationship study. IUBMB Life 2008, 60(12): 853-8.
14. Patanasethanont, D., Nagai, J., Matsuura, C. et al. Modulation of function of multidrug resistance associated-proteins by Kaempferia parviflora extracts and their components. Eur J Pharmacol 2007, 566(2): 67-74.
15. Zhou, S., Lim, L.Y., Chowbay, B. Herbal modulation of P-glycoprotein. Drug Metab Rev 2004,36(1): 57-104.
16. Di Pietro, A., Conseil, G., Pérez-Victoria, J.M. et al. Modulation by flavonoids of cell multidrug resistance mediated by P-glycoprotein and related ABC transporters. Cell Mol Life Sci 2002, 59(2): 307-22.
17. Ohtani, H., Ikegawa, T., Honda, Y. et al. Effects of various methoxyflavones on vincristine uptake and multidrug resistance to vincristine in P-gp-over-expressing K562/ADM cells. Pharm Res 2007,24(10): 1936-43.
18. Hahn, J.S., Neef, D.W., Thiele, D.J. A stress regulatory network for co-ordinated activation of proteasome expression mediated by yeast heat shock transcription factor. Mol Microbiol 2006, 60(1): 240-51.
19. Shen, J., Zhang, W.J., Wu, J., Zhu, Y.F. The synergistic reversal effect of multidrug resistance by quercetin and hyperthermia in doxorubicin-resistant human myelogenous leukemia cells. lnt J Hyperther 2008,24(2): 151-9.
20. Fang, J.Y., Tsai, T.H., Lin, Y.Y., Wong, W.W., Wang, M.N., Huang, J.F. Transdermal delivery of tea catechins and theophylline enhanced by terpenes: A mechanistic study. Biol Pharm Bull 2007,30(2): 343-9.
21. Mei, Y., Qian, F., Wei, D., Liu, J. Reversal of cancer multidrug resistance by green tea polyphenols. J Pharm Pharmacol 2004, 56(10): 1307-14.
22. Mei, Y., Wei, D., Liu, J. Reversal of multidrug resistance in KB cells with tea polyphenol antioxidant capacity. Cancer Biol Ther 2005,4(4): 468-73.
23. Morrow, C.S., Peklak-Scott, C., Bishwokarma, B., Kute, T.E., Smitherman, P.K., Townsend, A.J. Multidrug resistance protein 1 (MRP1 ABCC1) mediates resistance to mitoxantrone via glutathione-dependent drug efflux. Mol Pharmacol 2006,69(4): 1499-505.
24. Cai, X., Chen, F.Y., Han, J.Y., Gu, CH, Zhong, H., Teng, Y., Ouyang, R.R. Reversal of multidrug resistance of HL-60 adriamycin resistant leukemia cell line by quercetin and its mechanisms. Zhonghua Zhong Liu Za Zhi 2005,27(6): 326-9.
25. Cai, X., Chen, F.Y., Han, J.Y., Gu, C.H., Zhong, H., Ouyang, R.R. Restore effect of quercetin on subcellular distribution of daunorubicin in multidrug resistant leukemia cell lines K562/ADM and HL-60/ADM. Ai Zheng 2004, 23(12): 1611-5.
26. Rothnie, A., Conseil, G., Lau, A.Y., Deeley, R.G., Cole, S.P. Mechanistic differences between GSH transport by multidrug resistance protein 1 (MRP1/ABCC1) and CSH modulation of MRP1-mediated transport. Mol Pharmacol 2008,74(6): 1630-40.
27. Nguyen, H., Zhang, S., Morris, M.F. Effect of flavonoids on MRP1-mediated transport in Panc-1 cells. J Pharm Sci 2003, 92(2): 250-7.
28. Wiese, M., Pajeva, I.K. Structure-activity relationships of multidrug resistance reversers. Curr Med Chem 2001, 8(6): 685-713.
29. Lawrence, D.S., Copper, J.E., Smith, C.D. Structure-activity studies of substituted quinoxalinones as multiple-drug-resistance antagonists. J Med Chem 2001, 44(4): 594-601.
30. He, L., Liu, G.Q. Effects of various principles from Chinese herbal medicine on rhodaminel23 accumulation in brain capillary endothelial cells. Acta Pharmacol Sin 2002,23(7): 591-6.
31. He, Q.Y., Meng, F.H., Zhang, H.Q. Reduction of doxorubicin resistance by tetrandrine and dauricine in harringtonine-resistant human leukemia (HL60) cells. Zhongguo Yao Li Xue Bao 1996,17(2): 179-81.
32. Zhu, X., Sui, M., Fan, W. In vitro and in vivo characterizations of tetrandrine on the reversal of P-glycoprotein-mediated drug resistance to paclitaxel. Anticancer Res 2005, 25(3B): 1953-62.
33. Liu, Z.L., Hirano, T., Tanaka, S., Onda, K., Oka, K. Persistent reversal of P-glycoprotein-mediated dounorubicin resistance by tetrandrine in multidrug-resistant human T lymphoblastoid leukemia MOLT-4 cells. J Pharm Pharmacol 2003, 55(11): 1531-7.
34. Fu, L., Liang, Y., Deng, L. et al. Characterization of tetrandrine, a potent inhibitor of P-glycoprotein-mediated multidrug resistance. Cancer Chemother Pharmacol 2004, 53(4): 349-56.
35. Xu, W.L., Shen, H.L., Ao, Z.F., Chen, B.A., Xia, W., Gao, F., Zhang, Y.N. Combination of tetrandrine as a potential-reversing agent with daunorubicin, etoposide and cytarabine for the treatment of refractory and relapsed acute myelogenous leukemia. Leuk Res 2006,30(4): 407-13.
36. Jin, J., Wang, F.P., Wei, H., Liu, G. Reversal of multidrug resistance of cancer through inhibition of P-glycoprotein by 5-bromotetrandrine. Cancer Chemother Pharmacol 2005, 55(2): 179-88.
37. Lavie, Y., Harel-Orbital, T., Gaffield, W., Liscovitch, M. Inhibitory effect of steroidal alkaloids on drug transport and multidrug resistance in human cancer cells. Anticancer Res 2001,21(2A): 1189-94.
38. Mi, Q., Cui, B., Silva, G.L. et al. Pervilleine A, a novel tropane alkaloid that reverses the multidrug-resistance phenotype. Cancer Res 2001, 61(10): 4030-7.
39. Mei, Y., Shi, Y., Zuo, G.Q., Gong, J.P., Liu, C.A., Li, X.H., Ren, M.J. Study on ligustrazine in reversing multidrug resistance of HepG2/ADM cell in vitro. China J Chin Materia Med 2004,29(10): 970-3.
40. Rajput, Z.I, Hu, S.H., Xiao, CW, Arijo, A.G. Adjuvant effects of saponins on animal immune responses. Zhejiang Univ Sci B 2007, 8(3): 153-61.
41. Guo, Y.Q., Liu, J.X., Lu, Y., Zhu, W.Y., Denman, S.E., McSweeney, C.S. Effect of tea saponin on methanogenesis, microbial community structure and expression of mcrA gene, in cultures of rumen micro-organisms. Lett Appl Microbiol 2008,47(5): 421-6.
42. Molnar, J., Szabo, D., Pusztai, R. et al. Membrane associated antitumor effects of crocine-, ginsenoside- and cannabinoid derivatives. Anticancer Res 2000, 20(2A): 861-7.
43. 3. Biochem Pharmacol 2003, 65(1): 75-82.
44. Kwon, H.Y., Kim, E.H., Kim, S.W., Kim, S.N., Park, J.D., Rhee, D.K. Selective toxicity of ginsenoside Rg3 on multidrug resistant cells by membrane fluidity modulation. Arch Pharm Res 2008, 31(2): 171-7.